title: Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer Vaccines.
abstract: Cancer vaccine boost via the cervicovaginal rather than the intramuscular route of immunization appears to be crucial to induce genital CD8(+) T cells and tumor regression. This clinical activity is correlated with the ability of the mucosal boost to elicit resident memory T cells in the genital tract.
authors.affiliation: INSERM U970, Paris Cardiovascular Research Center, Université Paris-Descartes, Sorbonne Paris Cité, Paris, France. Equipe Labellisée Ligue Contre le Cancer, Paris, France.
authors.forename: Mevyn
authors.initials: M
authors.lastname: Nizard
authors.affiliation: INSERM U970, Paris Cardiovascular Research Center, Université Paris-Descartes, Sorbonne Paris Cité, Paris, France. Equipe Labellisée Ligue Contre le Cancer, Paris, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Roussel
authors.affiliation: INSERM U970, Paris Cardiovascular Research Center, Université Paris-Descartes, Sorbonne Paris Cité, Paris, France. Equipe Labellisée Ligue Contre le Cancer, Paris, France. Hôpital Européen Georges Pompidou, Service d'immunologie biologique, Paris, France. eric.tartour@aphp.fr.
authors.forename: Eric
authors.initials: E
authors.lastname: Tartour
mesh_terms: D015415:Biomarkers; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines; D006801:Humans; D007114:Immunization; D007156:Immunologic Memory; D009369:Neoplasms
chemical_list: D015415:Biomarkers; D019496:Cancer Vaccines